We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Pneumococcal Vaccines Market by Vaccine Type (Pneumococcal Conjugate Vaccine (PCV), Pneumococcal Polysaccharide Vaccine (PPSV/PPV)), by Product Type (Prevnar 13, Synflorix, Pneumovax 23) Global Outlook & Forecast 2022-2030

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The Pneumococcal Vaccines Market is predicted to reach US$ by 2030 from US$ 8.3 billion in 2021, and to grow at a CAGR of 5.20% between the forecast period 2022 to 2030.

The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.

Major segmentation covered in this report is as follows:

By Vaccine Type (Pneumococcal Conjugate Vaccine (PCV), Pneumococcal Polysaccharide Vaccine (PPSV/PPV)), by Product Type (Prevnar 13, Synflorix, Pneumovax 23)

By Region

North America, Europe, Asia Pacific, and the Rest of the World

Major market players covered in this study are

Astellas Pharma Inc., GlaxoSmithKline Plc., Merck & Co. Inc., Panacea Biotech Ltd., Pfizer Inc., Sanofi S.A., Walvax Biotechnology Co. Ltd, CSL Ltd., Serum Institute of India Pvt. Ltd., and Talley Group Ltd.

1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Pneumococcal Vaccines - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Pneumococcal Vaccines - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Pneumococcal Vaccines - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Pneumococcal Vaccines - ANALYSIS & FORECAST, BY REGION
North America Pneumococcal Vaccines
1. North America Pneumococcal Vaccines , by Country
1. US
2. Canada
1. North America Pneumococcal Vaccines , by Product
2. North America Pneumococcal Vaccines , by Type
3. North America Pneumococcal Vaccines , by Gender
4. North America Pneumococcal Vaccines , by Sales Channel
3. Europe Pneumococcal Vaccines
1. Europe Pneumococcal Vaccines , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Pneumococcal Vaccines , by Product
3. Europe Pneumococcal Vaccines , by Type
4. Europe Pneumococcal Vaccines , by Gender
5. Europe Pneumococcal Vaccines , by Sales Channel
4. Asia Pacific Pneumococcal Vaccines
1. Asia Pacific Pneumococcal Vaccines , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Pneumococcal Vaccines , by product
3. Asia Pacific Pneumococcal Vaccines , by Type
4. Asia Pacific Pneumococcal Vaccines , by Gender
5. Asia Pacific Pneumococcal Vaccines , by Sales Channel
5. Rest of the World Pneumococcal Vaccines
1. Rest of the World Pneumococcal Vaccines , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Pneumococcal Vaccines , by Product
3. Rest of the World Pneumococcal Vaccines , by Type
4. Rest of the World Pneumococcal Vaccines , by Gender
5. Rest of the World Pneumococcal Vaccines , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 39

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved